Is whole genome sequencing fading? Will it rebound (or relapse)?
There are various informal indicators that funders are losing enthusiasm for human whole genome sequencing. [. . .] If this turns out to be more than a few anecdotes or personal opinions, and is actually occurring, it's understandable and to be lauded. As we think we can truthfully claim, we have for years been warning of the dangers of the kind of overkill that genomics (and, indeed, other 'omics' fads) present: promise miracles and you had better deliver!
The same thing applies to evolutionary studies that seek whole genome sequences as well as to studies designed to use such data to predict individual diseases. There are too many variants to sort through, the individual signal is too weak, and too many parts of the genome contribute to many if not most traits, for genomes to be all that important--whether for predicting future disease, normal phenotypes like behaviors, or fitness in the face of natural selection.
The proper response to genomic complexity is of course not to throw ones hands up and go back to candidate gene studies, but to sequence lots and lots of genomes in full. This is what needs to happen, and falling sequencing costs mean this is what will happen, regardless of what Ken Weiss wants.
Note: Ken Weiss is "Evan Pugh Professor of Anthropology and Genetics at Penn State University". I can think of a few possibilities: (1) Weiss is sincere in believing medical science and evolutionary research would be better advanced with less whole genome sequencing; he's not malicious -- just short-sighted, unimaginative, and breathtakingly ignorant of the broader state of his supposed academic specialty. (2) Weiss is merely jealous that his colleagues are getting bigger grants than him, a frailty he could perhaps be forgiven. (3) "Anthropology and Genetics" professor Weiss, for some reason, prefers that human evolutionary and genetics research not advance.
Looking at some of his other posts, I see plenty of evidence ethnic and/or ideological considerations underpin Weiss's "warnings" about genomics.